CLINICAL_TRIALS
trial_result
· 2022-12-21
Clinical Trial Update: Dexamethasone in Controlling Dyspnea in Patients With Cancer [Phase 2]
Summary
Phase 2 clinical trial evaluating dexamethasone to control dyspnea in patients with cancer; results were posted in December 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Dyspnea, Malignant Neoplasm | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-12-21